IAM Advisory LLC Boosts Stock Holdings in Zoetis Inc. (NYSE:ZTS)

IAM Advisory LLC boosted its position in Zoetis Inc. (NYSE:ZTS) by 2.6% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 10,022 shares of the company’s stock after purchasing an additional 251 shares during the quarter. IAM Advisory LLC’s holdings in Zoetis were worth $1,633,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of ZTS. Veery Capital LLC lifted its stake in Zoetis by 2.8% in the 4th quarter. Veery Capital LLC now owns 2,465 shares of the company’s stock worth $402,000 after purchasing an additional 68 shares in the last quarter. Raub Brock Capital Management LP boosted its stake in Zoetis by 2.1% during the fourth quarter. Raub Brock Capital Management LP now owns 88,807 shares of the company’s stock worth $14,469,000 after buying an additional 1,832 shares during the last quarter. HB Wealth Management LLC grew its holdings in Zoetis by 16.0% in the 4th quarter. HB Wealth Management LLC now owns 13,565 shares of the company’s stock valued at $2,210,000 after buying an additional 1,867 shares in the last quarter. Sanibel Captiva Trust Company Inc. acquired a new position in shares of Zoetis during the 4th quarter valued at about $232,000. Finally, Arkadios Wealth Advisors grew its holdings in shares of Zoetis by 9.7% in the fourth quarter. Arkadios Wealth Advisors now owns 5,534 shares of the company’s stock valued at $902,000 after purchasing an additional 489 shares during the period. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several analysts have recently weighed in on the stock. Leerink Partners initiated coverage on shares of Zoetis in a research note on Monday, December 2nd. They issued an “outperform” rating and a $215.00 price target for the company. Leerink Partnrs upgraded Zoetis to a “strong-buy” rating in a research report on Monday, December 2nd. UBS Group began coverage on shares of Zoetis in a research report on Monday, December 9th. They set a “neutral” rating and a $196.00 price target on the stock. Stifel Nicolaus cut their target price on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating on the stock in a research note on Tuesday, January 7th. Finally, JPMorgan Chase & Co. upped their price objective on Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. One investment analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, Zoetis presently has a consensus rating of “Buy” and an average target price of $211.89.

Zoetis Stock Down 2.0 %

Shares of NYSE ZTS opened at $166.01 on Friday. The business has a 50-day moving average of $170.93 and a two-hundred day moving average of $179.95. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.69 and a quick ratio of 2.27. The company has a market capitalization of $74.90 billion, a price-to-earnings ratio of 31.20, a price-to-earnings-growth ratio of 2.51 and a beta of 0.89. Zoetis Inc. has a 1 year low of $144.80 and a 1 year high of $200.53.

Zoetis (NYSE:ZTS) last issued its earnings results on Monday, November 4th. The company reported $1.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.46 by $0.12. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. The business had revenue of $2.40 billion during the quarter, compared to analysts’ expectations of $2.29 billion. During the same quarter in the prior year, the business posted $1.36 EPS. The company’s revenue for the quarter was up 11.6% on a year-over-year basis. On average, analysts forecast that Zoetis Inc. will post 5.91 earnings per share for the current fiscal year.

Zoetis Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 4th. Stockholders of record on Tuesday, January 21st will be issued a $0.50 dividend. This is an increase from Zoetis’s previous quarterly dividend of $0.43. This represents a $2.00 annualized dividend and a dividend yield of 1.20%. The ex-dividend date of this dividend is Tuesday, January 21st. Zoetis’s payout ratio is presently 32.52%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.